Pharmacokinetics, efficacy and safety of glyburide for treatment of gestational diabetes mellitus

References

• Ferrara A. Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care. 2007;30(Suppl 2):S141–146.
   PubMed Web of Science ®Google Scholar
• Freinkel N: Banting Lecture. Of pregnancy and progeny. Diabetes. 1980;29:1023–1035.
   PubMed Web of Science ®Google Scholar
• Wendland EM, Torloni MR, Falavigna M, et al. Gestational diabetes and pregnancy outcomes – a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria. BMC Pregnancy Childbirth. 2012;12:23.
   PubMed Web of Science ®Google Scholar
• Boney CM, Verma A, Tucker R, et al. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics. 2005;115:e290–296.
   PubMed Web of Science ®Google Scholar
• Clausen TD, Mathiesen ER, Hansen T, et al. High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine hyperglycemia. Diabetes Care. 2008;31:340–346.
   PubMed Web of Science ®Google Scholar
• Metzger BE. Long-term outcomes in mothers diagnosed with gestational diabetes mellitus and their offspring. Clin Obstet Gynecol. 2007;50:972–979.
   PubMed Web of Science ®Google Scholar
• Feig DS, Razzaq A, Sykora K, et al. Trends in deliveries, prenatal care, and obstetrical complications in women with pregestational diabetes: a population-based study in Ontario, Canada, 1996–2001. Diabetes Care. 2006;29:232–235.
   PubMed Web of Science ®Google Scholar
• Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care. 2002;25:1862–1868.
   PubMed Web of Science ®Google Scholar
• Carr DB, Utzschneider KM, Hull RL, et al. Gestational diabetes mellitus increases the risk of cardiovascular disease in women with a family history of type 2 diabetes. Diabetes Care. 2006;29:2078–2083.
   PubMed Web of Science ®Google Scholar
• Retnakaran R, Qi Y, Connelly PW, et al. Glucose intolerance in pregnancy and postpartum risk of metabolic syndrome in young women. J Clin Endocrinol Metab. 2010;95:670–677.
   PubMed Web of Science ®Google Scholar
• Langer O, Conway DL, Berkus MD, et al. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med. 2000;343:1134–1138. •• This paper was the first trial confirming clinical efficacy of glyburide for treatment of GDM. There were no safety concerns raised with this paper.
   PubMed Web of Science ®Google Scholar
• Ogunyemi DA, Fong A, Rad S, et al. Attitudes and practices of healthcare providers regarding gestational diabetes: results of a survey conducted at the 2010 meeting of the International Association of Diabetes in Pregnancy Study Group (IADPSG). Diabet Med. 2011;28:976–986.
   PubMed Web of Science ®Google Scholar
• Camelo Castillo W, Boggess K, Stürmer T, et al. Trends in glyburide compared with insulin use for gestational diabetes treatment in the United States, 2000–2011. Obstet Gynecol. 2014;123:1177–1184. ••This paper highlighted the widespread off-label use of glyburide for GDM.
   PubMed Web of Science ®Google Scholar
• Feldman JM. Glyburide: a second-generation sulfonylurea hypoglycemic agent. History, chemistry, metabolism, pharmacokinetics, clinical use and adverse effects. Pharmacotherapy. 1985;5:43–62.
   PubMed Web of Science ®Google Scholar
• Jaber LA, Antal EJ, Slaughter RL, et al. Comparison of pharmacokinetics and pharmacodynamics of short- and long-term glyburide therapy in NIDDM. Diabetes Care. 1994;17:1300–1306.
   PubMed Web of Science ®Google Scholar
• Ravindran S, Zharikova OL, Hill RA, et al. Identification of glyburide metabolites formed by hepatic and placental microsomes of humans and baboons. Biochem Pharmacol. 2006;72:1730–1737.
   PubMed Web of Science ®Google Scholar
• Rydberg T, Jönsson A, Røder M, et al. Hypoglycemic activity of glyburide (glibenclamide) metabolites in humans. Diabetes Care. 1994;17:1026–1030.
   PubMed Web of Science ®Google Scholar
• Elliott BD, Langer O, Schenker S, et al. Insignificant transfer of glyburide occurs across the human placenta. Am J Obstet Gynecol. 1991;165:807–812.
   PubMed Web of Science ®Google Scholar
• Koren G. Glyburide and fetal safety; transplacental pharmacokinetic considerations. Reprod Toxicol. 2001;15:227–229.
   PubMed Web of Science ®Google Scholar
• Hebert MF, Ma X, Naraharisetti SB, et al. Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice. Clin Pharmacol Ther. 2009;85:607–614. •This paper highlighted the unique pharmacology of glyburide in pregnant women.
   PubMed Web of Science ®Google Scholar
• Schwartz RA, Rosenn B, Aleksa K, et al. Glyburide transport across the human placenta. Obstet Gynecol. 2015;125:583–588.
   PubMed Web of Science ®Google Scholar
• Shuster DL, Risler LJ, Prasad B, et al. Identification of CYP3A7 for glyburide metabolism in human fetal livers. Biochem Pharmacol. 2014;92:690–700.
   PubMed Web of Science ®Google Scholar
• Kraemer J, Klein J, Lubetsky A, et al. Perfusion studies of glyburide transfer across the human placenta: implications for fetal safety. Am J Obstet Gynecol. 2006;195:270–274.
   PubMed Web of Science ®Google Scholar
• Ganapathy V, Prasad PD, Ganapathy ME, et al. Placental transporters relevant to drug distribution across the maternal-fetal interface. J Pharmacol Exp Ther. 2000;294:413–420.
   PubMed Web of Science ®Google Scholar
• Nanovskaya TN, Nekhayeva I, Hankins GD, et al. Effect of human serum albumin on transplacental transfer of glyburide. Biochem Pharmacol. 2006;72:632–639.
   PubMed Web of Science ®Google Scholar
• Maliepaard M, Scheffer GL, Faneyte IF, et al. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res. 2001;61:3458–3464.
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Ikeda S, Furukawa T, et al. Function of P-glycoprotein expressed in placenta and mole. Biochem Biophys Res Commun. 1997;235:849–853.
   PubMed Web of Science ®Google Scholar
• St-Pierre MV, Serrano MA, Macias RI, et al. Expression of members of the multidrug resistance protein family in human term placenta. Am J Physiol Regul Integr Comp Physiol. 2000;279:R1495–1503.
   PubMed Web of Science ®Google Scholar
• Gedeon C, Behravan J, Koren G, et al. Transport of glyburide by placental ABC transporters: implications in fetal drug exposure. Placenta. 2006;27:1096–1102.
   PubMed Web of Science ®Google Scholar
• Gedeon C, Anger G, Piquette-Miller M, et al. Breast cancer resistance protein: mediating the trans-placental transfer of glyburide across the human placenta. Placenta. 2008;29:39–43.
   PubMed Web of Science ®Google Scholar
• Pollex E, Lubetsky A, Koren G. The role of placental breast cancer resistance protein in the efflux of glyburide across the human placenta. Placenta. 2008;29:743–747. •This paper defined the role of the BCRP in glyburide efflux across the human placenta.
   PubMed Web of Science ®Google Scholar
• Pollex EK, Anger G, Hutson J, et al. Breast cancer resistance protein (BCRP)-mediated glyburide transport: effect of the C421A/Q141K BCRP single-nucleotide polymorphism. Drug Metab Dispos. 2010;38:740–744.
   PubMed Web of Science ®Google Scholar
• Zhou L, Naraharisetti SB, Liu L, et al. Contributions of human cytochrome P450 enzymes to glyburide metabolism. Biopharm Drug Dispos. 2010;31:228–242.
   PubMed Web of Science ®Google Scholar
• Zhou L, Zhang Y, Hebert MF, et al. Increased glyburide clearance in the pregnant mouse model. Drug Metab Dispos. 2010;38:1403–1406.
   PubMed Web of Science ®Google Scholar
• Anger GJ. Piquette-Miller M: Impact of hyperlipidemia on plasma protein binding and hepatic drug transporter and metabolic enzyme regulation in a rat model of gestational diabetes. J Pharmacol Exp Ther. 2010;334:21–32. •This paper showed that plasma lipids impact the degree of glyburide transfer across the placenta.
   PubMed Web of Science ®Google Scholar
• Myngheer N, Allegaert K, Hattersley A, et al. Fetal macrosomia and neonatal hyperinsulinemic hypoglycemia associated with transplacental transfer of sulfonylurea in a mother with KCNJ11-related neonatal diabetes. Diabetes Care. 2014;37:3333–3335.
   PubMed Web of Science ®Google Scholar
• Jacobson GF, Ramos GA, Ching JY, et al. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization. Am J Obstet Gynecol. 2005;193:118–124. •This large study noted increased rates of preeclampsia and longer NICU admissions in mothers on glyburide for GDM.
   PubMed Web of Science ®Google Scholar
• Mirzamoradi M, Heidar Z, Faalpoor Z, et al. Comparison of glyburide and insulin in women with gestational diabetes mellitus and associated perinatal outcome: a randomized clinical trial. Acta Med Iran. 2015;53:97–103.
   PubMedGoogle Scholar
• Anjalakshi C, Balaji V, Balaji MS, et al. A prospective study comparing insulin and glibenclamide in gestational diabetes mellitus in Asian Indian women. Diabetes Res Clin Pract. 2007;76:474–475.
   PubMed Web of Science ®Google Scholar
• Jiang Y-F, Chen X-Y, Ding T, et al. Comparative efficacy and safety of OADs in management of GDM: network meta-analysis of randomized controlled trials. J Clin Endocrinol Metab. 2015;100:2071–2080.
   PubMed Web of Science ®Google Scholar
• Conway DL, Gonzales O, Skiver D: Use of glyburide for the treatment of gestational diabetes: the San Antonio experience. J Matern Fetal Neonatal Med. 2004;15:51–55.
   PubMedGoogle Scholar
• Chmait R, Dinise T, Moore T. Prospective observational study to establish predictors of glyburide success in women with gestational diabetes mellitus. J Perinatol. 2004;24:617–622.
   PubMedGoogle Scholar
• Moretti ME, Rezvani M. Koren G: Safety of glyburide for gestational diabetes: a meta-analysis of pregnancy outcomes. Ann Pharmacother. 2008;42:483–490.
   PubMed Web of Science ®Google Scholar
• Ramos GA, Jacobson GF, Kirby RS, et al. Comparison of glyburide and insulin for the management of gestational diabetics with markedly elevated oral glucose challenge test and fasting hyperglycemia. J Perinatol. 2007;27:262–267.
   PubMed Web of Science ®Google Scholar
• Cheng YW, Chung JH, Block-Kurbisch I, et al. Treatment of gestational diabetes mellitus: glyburide compared to subcutaneous insulin therapy and associated perinatal outcomes. J Matern Fetal Neonatal Med. 2012;25:379–384.
   PubMed Web of Science ®Google Scholar
• Camelo Castillo W, Boggess K, Stürmer T, et al. Association of adverse pregnancy outcomes with glyburide vs insulin in women with gestational diabetes. JAMA Pediatr. 2015;169:452–458.
   PubMed Web of Science ®Google Scholar
• Yogev Y, Ben-Haroush A, Chen R, et al. Undiagnosed asymptomatic hypoglycemia: diet, insulin, and glyburide for gestational diabetic pregnancy. Obstet Gynecol. 2004;104:88–93.
   PubMed Web of Science ®Google Scholar
• Hernandez TL, Friedman JE, Van Pelt RE, et al. Patterns of glycemia in normal pregnancy: should the current therapeutic targets be challenged?. Diabetes Care. 2011;34:1660–1668.
   PubMed Web of Science ®Google Scholar
• Stark Casagrande S, Fradkin JE, Saydah SH, et al. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010. Diabetes Care. 2013;36:2271–2279.
   PubMed Web of Science ®Google Scholar
• Gangji AS, Cukierman T, Gerstein HC, et al. A systematic review and meta-analysis of hypoglycemia and cardiovascular events: a comparison of glyburide with other secretagogues and with insulin. Diabetes Care. 2007;30:389–394.
   PubMed Web of Science ®Google Scholar